跳至主要内容
临床试验/JPRN-UMIN000020291
JPRN-UMIN000020291已完成未知

Analysis of efficacy and safety of the stimulation of primary motor cortex with rTMS (TEN-P11) in the intractable neuropathic pain - Analysis of efficacy and safety of rTMS(TEN-P11) of primary motor cortex in the intractable neuropathic pain

Osaka University Medical Hospital0 个研究点目标入组 144 人开始时间: 2015年12月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with dementia (MMSE=<24) 2)Patients with severe aphasia or higher brain dysfunction 3)Patients with a major psychiatric disease 4)Patients with a desire for suicide 5)Patients with a history of epileptic attacks 6)Patients with an implantable stimulator including a cardiac pacemaker, except an impantable spinal cord stimulator 7)Patients with an implanted metal, except for titanium products, in their heads 8)Patients with an implanted pump or mechanical heart 8)Patients who cannot write questionaires 9)Patients showing complete paralysis in painful evaluation area 10)Patients without ability of agreements 11)Patients receiving rTMS within a year before agreements 12)Patients receiving other clinical trials or studies within 6 months before agreements 13)Compliance of patients for prohibited drugs and treatments is under 80% 14)Patients who are considered unsuitable for this clinical trial by a principal or sub investigator

研究者

发起方
Osaka University Medical Hospital

相似试验

进行中(未招募)
不适用
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiter
EUCTR2005-004451-35-NLGenzyme Europe BV99
进行中(未招募)
不适用
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiter - NDMultinodular goiterMedDRA version: 6.1Level: PTClassification code 10018498
EUCTR2005-004451-35-ITGenzyme Europe BV99
进行中(未招募)
不适用
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiter
EUCTR2005-004451-35-DKGenzyme Europe BV99
进行中(未招募)
1 期
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiterodular goiter are clinically recognizable enlargements of the thyroid gland characterized by excessive growth and structural and or functional transformation of one or several areas within the normal thyroid tissue.MedDRA version: 9.1Level: LLTClassification code 10043808Term: Thyrotropin
EUCTR2005-004451-35-FRGenzyme Europe BV99
进行中(未招募)
不适用
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiterodular goiter are clinically recognizable enlargements of the thyroid gland characterized by excessive growth and structural and or functional transformation of one or several areas within the normal thyroid tissue.MedDRA version: 9.1Level: LLTClassification code 10043808Term: Thyrotropin
EUCTR2005-004451-35-DEGenzyme Europe BV99